Mon.-Fri.: 1000-1900

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

We represented our client («DIAMED-Pharma» LLC) in an invalidation action filed by their competitor («Grotesk» LLC) against the decision of the Federal Antimonopoly Service of the Moscow Region, which had recognized the launch of «Artogistan» medication, aimed at arthrological diseases treatment, as an unfair competition act, since in that medication an invention under Russian patent №2612014, the owner of which is our client, had been illegally used.

The Court dismissed the invalidation action by the decision of May 27, 2021. Dr. Aleksey Zalesov, Patent Attorney and Advocate, represented the client before the Court. For more details about the case please follow the link.

Latest news